BMJ Open (May 2022)

Effects of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide on glucose metabolism in patients with type 2 diabetes: protocol for a multicentre, prospective, randomised, open-label, parallel-group comparison study (the SWITCH-SEMA 2 study)

  • Kyu Yong Cho,
  • Hiroki Yokoyama,
  • Tatsuya Atsumi,
  • Hiroshi Nomoto,
  • Jun Takeuchi,
  • So Nagai,
  • Yoshio Kurihara,
  • Shin Aoki,
  • Akinobu Nakamura,
  • Hideaki Miyoshi,
  • Shinji Taneda,
  • Ichiro Sakuma,
  • Sho Furusawa,
  • Aika Miya,
  • Hiraku Kameda

DOI
https://doi.org/10.1136/bmjopen-2021-056885
Journal volume & issue
Vol. 12, no. 5

Abstract

Read online

No abstracts available.